Microglia in Alzheimer's disease
David V Hansen1, Jesse E Hanson2, Morgan Sheng3
1Department of Neuroscience, Genentech, Inc., South San Francisco, CA hansen.david@gene.com.
Abstract:
Proliferation and activation of microglia in the brain, concentrated around amyloid plaques, is a prominent feature of Alzheimer's disease (AD). Human genetics data point to a key role for microglia in the pathogenesis of AD. The majority of risk genes for AD are highly expressed (and many are selectively expressed) by microglia in the brain. There is mounting evidence that microglia protect against the incidence of AD, as impaired microglial activities and altered microglial responses to β-amyloid are associated with increased AD risk. On the other hand, there is also abundant evidence that activated microglia can be harmful to neurons. Microglia can mediate synapse loss by engulfment of synapses, likely via a complement-dependent mechanism; they can also exacerbate tau pathology and secrete inflammatory factors that can injure neurons directly or via activation of neurotoxic astrocytes. Gene expression profiles indicate multiple states of microglial activation in neurodegenerative disease settings, which might explain the disparate roles of microglia in the development and progression of AD pathology.
Insights
Microglia play a dual role in Alzheimer's disease (AD), potentially protecting against or harming the brain. Understanding their complex functions is crucial for developing effective AD treatments.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Microglia, the brain's immune cells, are implicated in Alzheimer's disease (AD) pathogenesis, with many AD risk genes highly expressed in these cells.
- Evidence suggests microglia may protect against AD, as impaired function is linked to increased risk.
- Conversely, activated microglia can harm neurons, exacerbating AD pathology through synapse loss, tau spread, and inflammation.
Purpose of the Study:
- To explore the multifaceted roles of microglia in Alzheimer's disease.
- To reconcile the seemingly contradictory protective and detrimental effects of microglia in AD.
Main Methods:
- Analysis of human genetics data.
- Review of existing evidence on microglial function in AD.
- Examination of gene expression profiles in neurodegenerative diseases.
Main Results:
- Microglia exhibit diverse activation states in neurodegenerative conditions.
- Genetic data highlight microglia's central role in AD.
- Microglial activity can be both protective and detrimental to neuronal health and AD progression.
Conclusions:
- Microglia possess complex, context-dependent roles in Alzheimer's disease.
- Their dual function may stem from distinct activation states.
- Further research into microglial states is essential for understanding AD and developing therapies.
Related Concept Videos
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:22Alzheimer's Disease: Treatment